Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Laryngol Otol ; 118(11): 857-61, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15638971

ABSTRACT

A growing body of evidence suggests that a variety of upper respiratory symptoms (URS) are associated with gastro-oesophageal reflux (GORD). The aim of this study was to determine the prevalence of endoscopic erosive, and non-erosive, oesophagitis among patients complaining of persistent URS, in the absence of typical GORD symptoms, and to compare them with a comparison group of similar age. A group of 110 patients aged 18-75, presenting with persistent URS with no suspicion of GORD symptoms, underwent upper flexible endoscopy, with biopsy sampling for histology, and was compared with a group of 117 patients of similar age undergoing endoscopy for reasons other than GORD. Patients affected with upper airway disorders, such as posterior laryngitis, chronic sinusitis and vocal fold nodules, had a significantly higher prevalence of oesophagitis of varying degrees (31 per cent) compared to the comparison population (15.4 per cent) (p < 0.01). These data suggest that in many patients with chronic URS occult gastro-oesophageal diseases are present.


Subject(s)
Esophagitis/complications , Gastroesophageal Reflux/complications , Respiratory Tract Diseases/etiology , Adolescent , Adult , Aged , Chronic Disease , Esophagitis/diagnosis , Esophagitis/epidemiology , Esophagoscopy , Female , Gastroesophageal Reflux/diagnosis , Humans , Laryngeal Diseases/etiology , Male , Middle Aged , Prevalence , Sinusitis/etiology
2.
Digestion ; 66(3): 154-9, 2002.
Article in English | MEDLINE | ID: mdl-12481161

ABSTRACT

BACKGROUND: Rabeprazole has been demonstrated to be a potent antisecretory agent and has been shown to be clinically effective in the treatment of acid-related diseases. AIMS: It was to determine the efficacy of rabeprazole at 20 and 40 mg in addition to amoxicillin and clarithromycin in the treatment of active Helicobacter pylori-positive duodenal ulcers compared with omeprazole 40 mg. PATIENTS AND METHODS: One hundred and twenty-seven patients were randomised into three treatment groups: 40 patients were treated with rabeprazole 40 mg daily, 42 patients with rabeprazole 20 mg daily and 45 patients with omeprazole 40 mg daily for 10 days. All patients received amoxicillin 1 g twice a day and clarithromycin 500 mg twice a day for 5 days. All patients were re-assessed at least 4 weeks after the end of the treatment. RESULTS: According to the intention-to-treat (ITT) protocol, ulcer healing was observed in 90% of patients in the rabeprazole 40 group, in 85.7% in the rabeprazole 20 group and in 93.3% in the omeprazole 40 group. We observed H. pylori eradication in 90% ITT in the rabeprazole 40 group, in 80.9% ITT in the rabeprazole 20 group and in 88.8% ITT in the omeprazole 40 group. Statistical analysis did not show significant differences among the three groups. CONCLUSIONS: A 10-day rabeprazole 20 mg regimen represents an efficacious and safe regimen for H. pylori eradication and ulcer healing.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Benzimidazoles/therapeutic use , Duodenal Ulcer/drug therapy , Omeprazole/therapeutic use , 2-Pyridinylmethylsulfinylbenzimidazoles , Adult , Amoxicillin/therapeutic use , Clarithromycin/therapeutic use , Drug Administration Schedule , Drug Therapy, Combination , Female , Helicobacter Infections/drug therapy , Helicobacter pylori , Humans , Male , Patient Compliance , Prospective Studies , Proton-Translocating ATPases/therapeutic use , Rabeprazole
3.
Am J Physiol Lung Cell Mol Physiol ; 283(6): L1291-302, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12424147

ABSTRACT

We investigated the effect of altered extracellular pH, mitochondrial function, and ATP content on development of apoptosis in human pulmonary artery endothelial cells after treatment with staurosporine (STS). STS produced a concentration- and time-dependent increase in caspase-3 activity in pH 7.4 medium that reached a peak at 6 h. The increase in caspase activity was associated with significant DNA fragmentation. Fluorescent imaging of treated monolayers in pH 7.4 medium with Hoechst-33342-propidium iodide demonstrated a large percentage of apoptotic cells ( approximately 40%) with no evidence of necrosis. Caspase activity, DNA fragmentation, and percentage of apoptotic cells were reduced after STS treatment in acidic media (pH 7.0 and 6.6). The Ca2+ chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-AM inhibited STS-induced apoptosis, whereas the rise in intracellular Ca2+concentration in STS-treated cells in pH 7.4 medium was reduced in pH 7.0 medium. These results suggest that one mechanism for inhibitory effects of acidosis may be a pH-induced alteration in Ca2+ signaling. Treatment with STS in the presence of oligomycin (10 microM), an inhibitor of the mitochondrial F(0)F(1)-ATPase, in glucose-free media abolished caspase activation and DNA fragmentation in association with severe ATP depletion ( approximately 2% of control cells). Imaging demonstrated a change in the mode of cell death from apoptosis to necrosis under these conditions. This change was linked to the level of ATP depletion, because STS treatment in the absence of glucose or the presence of oligomycin in media with glucose still leads to apoptosis in the presence of only moderate ATP depletion. These results demonstrate that pH, mitochondrial function, and ATP supply are important variables that regulate STS-induced apoptosis in human pulmonary artery endothelial cells.


Subject(s)
Adenosine Triphosphate/physiology , Apoptosis/physiology , Endothelium, Vascular/physiology , Hydrogen/metabolism , Mitochondria/physiology , Pulmonary Artery/physiology , Adenosine Triphosphate/deficiency , Apoptosis/drug effects , Calcium/metabolism , Caspase 3 , Caspases/metabolism , Cells, Cultured , Cytosol/metabolism , DNA Fragmentation/physiology , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Enzyme Activation , Enzyme Inhibitors/pharmacology , Humans , Hydrogen-Ion Concentration , Pulmonary Artery/cytology , Pulmonary Artery/drug effects , Staurosporine/pharmacology
5.
Pharmacol Res ; 22(3): 271-6, 1990.
Article in English | MEDLINE | ID: mdl-2367278

ABSTRACT

In the present study we have assayed antioxidant enzymatic systems in erythrocytes from subjects with chronic cerebrovascular disease to correlate their involvement in red cell deformability. A significant decrease of glutathione peroxidase, reductase, catalase and superoxide dismutase activities has been found in human red blood cells from patients with chronic cerebrovascular disease when compared to the control group. The decrease in antioxidant enzymatic systems found in these patients was accompanied by reduced cellular resistance to hydrogen peroxide. An altered balance between the partially reduced forms of oxygen metabolism and the antioxidant enzymatic systems could play a crucial role in the haemorheological alteration frequently occurring in subjects affected by chronic cerebrovascular disease.


Subject(s)
Antioxidants/analysis , Cerebrovascular Disorders/enzymology , Erythrocytes/enzymology , Aged , Cerebrovascular Disorders/blood , Chronic Disease , Erythrocyte Deformability/physiology , Glucosephosphate Dehydrogenase/blood , Glutathione Peroxidase/blood , Glutathione Reductase/blood , Humans , Middle Aged , Superoxide Dismutase/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...